Purple Finance Ltd — Updates, 24-06-2025: Company Update
Purple Finance Limited
Registered Office: 11, Indu Chamber, 349/353, Samuel Street, Masjid Bunder West, Mumbai – 400003.
Corporate Office: 705/706, 7th Floor, Hallmark Business Plaza, Sant Dnyaneshwar Marg, Opp. Guru Nanak Hospital, Bandra (E), Mumbai- 400051
Tel. No.: +91-22 6916 5100 | www.purplefinance.in | CIN No. L67120MH1993PLC075037 | customersupport@purplefinance.in
Ref: PFL/BSE-CSE/2025-26/ 41
Date: June 24, 2025
To,
BSE Limited
The Corporate Relationship Department
P.J. Towers, 1st Floor,
Dalal Street,
Mumbai – 400 001
Scrip Code: 544191
Scrip ID: PURPLEFIN
To,
The Calcutta Stock Exchange
Limited,
7, Lyons Range,
Dalhousie, Kolkata-700001,
West Bengal
Scrip Code: 26505
Sub: Intimation under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements)
Regulations, 2015 and as per Regulation 92 of SEBI (Issue of Capital and Disclosure
Requirements) Regulations, 2018 with respect to Post-Rights Issue - Newspaper Publication.
Dear Sir/Madam,
Pursuant to Regulation 30 read with Part A of Schedule III and Regulation 47 of the SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015 and Regulation 92 of the Securities and
Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, we would like
to notify you that the Post-Issue Advertisement for the Rights Issue has been published on Tuesday, June
24, 2025 in the following newspapers:
1. Business Standard (English National daily newspaper with wide circulation);
2. Business Standard (Hindi National daily newspaper with wide circulation); and
3. Mumbai Lakshdeep (Marathi Edition).
In relation to the aforementioned, please find enclosed copy of the Post-Issue Advertisement dated June
24, 2025 in the above-mentioned newspapers.
You are requested to kindly take the same on your records.
Thanking You,
Yours faithfully,
For Purple Finance Limited
Ruchi Nishar
Company Secretary and Compliance Officer
Encl: A/a
----------------Page (0) Break----------------
4 COMMERCIAL
B
bbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbb
MUMBAI | TUESDAY, 24 JUNE 2025
NOTICE TO SHAREHOLDERS FOR TRANSFER OF UNCLAIMED DIVIDEND AND THEIR CORRESPONDING
EQUITY SHARES OF THE COMPANY TO INVESTOR EDUCATION AND PROTECTION FUND AUTHORITY
As per the provisions of Section 124 of the Companies Act, 2013 read with
the Investor Education and Protection Fund (“IEPF”) Authority
(Accounting, Audit, Transfer and Refund) Rules, 2016 and amendments
thereto, if any (“the Rules”), all the shares on which dividend has not been
encashed or claimed by the shareholders for seven consecutive years
(“concerned shares”), are to be transferred by the Company to the demat
account of the IEPF Authority.
The Company has communicated to the concerned shareholders (at the
registered address) who have not claimed their final dividend for the
financial year 2017-18 and all subsequent years and consequently whose
concerned shares are liable for transfer to IEPF. The full details of such
shareholders including their folio number or DP ID / Client ID are also
made available on the Company’s website www.alkemlabs.com. The
shareholders are requested to forward the requisite documents as
mentioned in the said communication at the email address of the
Company at investors@alkem.com or at the Company’s Registrar and
Share Transfer Agent at rnt.helpdesk@mpms.mufg.com on or before
th26 September, 2025:
SHAREHOLDERS HOLDING SHARES IN ELECTRONIC FORMshall
submit a self-attested copy of the client master list (demat account
statement) showing your name, address, demat and bank account details;
Payment will be made to the Bank Account registered against the Demat
account.
SHAREHOLDERS HOLDING SHARES IN PHYSICAL FORMshall
submit (a) the Investor Service Request Form ISR-1, Form ISR-2 and
Form No. SH-13 (Nomination Form) duly filled and signed as per the
instructions stated therein along with the supporting documents (the
Forms can be downloaded from the Company’s website
“www.alkemlabs.com” under the following path Investor Desk Forms)
(b) Copy of a cancelled cheque; (c) copy of PAN and Address proof; and (d)
copy of the Share Certificate.
In absence of receipt of valid claim by the shareholder for claiming their
final dividend for the financial year 2017-18 and all subsequent years, the
Company will be required to transfer the said unclaimed dividend amount
along with the concerned shares to IEPF Account without further notice, in
accordance with the requirements of the said Rules, by following the below
mentioned process:
In case shares are held:
• In physical form – New share certificate(s) will be issued and
transferred in favour of IEPF on completion of necessary formalities.
The original share certificate(s) which are registered in the name of
concerned shareholders will stand automatically cancelled and be
deemed non negotiable.
• In demat form – The Company shall inform the Depository by way of
corporate action for transfer of shares in favour of the demat account of
the IEPF Authority.
Consequent thereto, no claim shall lie against the Company in respect of
such unclaimed dividend amount and underlying shares transferred to
IEPF Account pursuant to the said Rules.
Concerned shareholders may note that both the unclaimed dividend
amount and the concerned shares transferred to IEPF Authority including
all the benefits accruing on such shares, if any, can be claimed back from
IEPF Authority after following the procedure prescribed under the Rules.
In case any shareholder has queries, grievances or issues in relation to the
above, they are requested to write an email to the Company’s Registrar
and Share Transfer Agent, MUFG Intime India Private Limited (Formerly
Link Intime India Private Limited) on rnt.helpdesk@mpms.mufg.com or
may contact Mr. Jay Prakash, VP, MUFG Intime India Private Limited, C-
101, 247 Park, L.B.S. Marg, Vikhroli (West), Mumbai - 400 083; Phone
Number: +91 8108114949.
ALKEM LABORATORIES LIMITED
CIN: L00305MH1973PLC174201
Registered Office: ‘Alkem House’, Senapati Bapat Marg, Lower Parel, Mumbai 400 013.
Phone: +91 22 3982 9999 Fax:+91 22 2495 2955
Website: www.alkemlabs.com, Email: investors@alkem.com
For Alkem Laboratories Limited
Sd/-
Manish Narang
President – Legal, Company Secretary &
Compliance OfficerPlace : MumbairdDate : 23 June, 2025
à
----------------Page (1) Break----------------
नई दिलली | मंगलवार, 24 जून 2025
4कमर्शल
----------------Page (2) Break----------------
----------------Page (3) Break----------------
